Ziccum AB (publ) to carry out Proof-of-Concept feasibility study for pharma formulation company
(Stockholm July 2, 2019) Ziccum AB (publ) (“Ziccum”) is carrying out an early-stage feasibility study for an innovative pharma company.The early-stage Proof of Concept study involves no financial exchange, but is to explore the compatibility of Ziccum’s air-drying capabilities with the company’s novel formulation. LaminarPace, Ziccum’s proprietary technology, air dries proteins, peptides and biologics at room temperature into stable, dry-form substances.